Abbott Laboratories ABT
NYSE ABT
$105.82 +0.30 (+0.28%)
As of: Sep 9, 2026 · 12:14 PM EDT

Abbott Laboratories (ABT) EBT Margin Growth (3y) (2012 - 2026)

Analysis

Abbott Laboratories (ABT) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 184.10 Bn 178.50 Bn 7.27 Bn -429.00
2 Intuitive Surgical 124.21 Bn 118.99 Bn 1.96 Bn 803.00
3 Medtronic 118.33 Bn 109.51 Bn 6.34 Bn 260.00
4 Stryker 104.21 Bn 100.73 Bn 4.50 Bn 574.00
5 Boston Scientific 66.39 Bn 65.86 Bn 3.85 Bn 764.00
6 Edwards Lifesciences 49.69 Bn 45.43 Bn 1.35 Bn 835.00
7 Alcon 33.94 Bn 32.48 Bn 1.68 Bn -1,045.00
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn 598.00
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn 423.00
10 Zimmer Biomet Holdings 18.14 Bn 17.73 Bn 1.54 Bn -309.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -429.00
Mar 31, 2026 -305.00
Dec 31, 2025 750.00
Sep 30, 2025 229.00
Jun 30, 2025 -160.00
Mar 31, 2025 -701.00
Dec 31, 2024 -179.00
Sep 30, 2024 -457.00
Jun 30, 2024 230.00
Mar 31, 2024 -513.00
Dec 31, 2023 -479.00
Sep 30, 2023 42.00
Jun 30, 2023 922.00
Mar 31, 2023 783.00
Dec 31, 2022 -183.00
Sep 30, 2022 323.00
Jun 30, 2022 708.00
Mar 31, 2022 1,579.00
Dec 31, 2021 256.00
Sep 30, 2021 1,343.00